SureTrader
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

I'm not saying this is the case here

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dmiller Member Profile
 
Followed By 21
Posts 11,135
Boards Moderated 1
Alias Born 01/02/03
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/15/2018 5:29:09 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2018 5:33:13 PM
Advaxis Submits Conditional Marketing Authorization Application for Axalimogene Filolisbac for the Second-Line Treatment of M... Business Wire - 2/13/2018 8:30:00 AM
Advaxis Announces Publication of Phase 2 Results Evaluating Axalimogene Filolisbac for the Treatment of Recurrent Metastatic ... Business Wire - 2/12/2018 9:15:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 2/6/2018 5:02:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2018 4:37:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2018 4:37:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2018 4:37:57 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/29/2018 5:04:42 PM
Data Highlighting Advaxis’ Antigen Delivery Platform Accepted for Multiple Presentations at 2018 Keystone Symposia Conferen... Business Wire - 1/29/2018 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 1/25/2018 5:04:55 PM
Traders News Source Issues Stocks on Watch and a New Feature Report InvestorsHub NewsWire - 1/25/2018 8:05:00 AM
Advaxis’ Immunotherapy in Combination with Chemoradiation Highlighted as Potential Treatment for Anal Cancer in Internation... Business Wire - 1/25/2018 8:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 1/9/2018 5:18:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 6:02:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 6:01:39 PM
Annual Report (10-k) Edgar (US Regulatory) - 12/21/2017 6:05:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/20/2017 4:21:23 PM
Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update Business Wire - 12/20/2017 4:15:00 PM
Aratana Therapeutics Granted Conditional License for a Canine Osteosarcoma Therapeutic PR Newswire (US) - 12/20/2017 8:05:00 AM
Advaxis to Host Business Update and Fiscal Year End 2017 Financial Results Conference Call on December 21, 2017 Business Wire - 12/14/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/4/2017 4:35:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/4/2017 4:31:53 PM
Quotidian Technical Highlights on Selected Biotech Stocks -- Advaxis, Grifols, Juno Therapeutics, and Lexicon Pharma PR Newswire (US) - 11/27/2017 7:05:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/9/2017 5:25:39 PM
dmiller   Wednesday, 09/13/17 07:27:34 PM
Re: blueyedcatch post# 33790
Post # of 55454 
I'm not saying this is the case here but let's be real...mgt's job is to put the best spin on things and project a positive future for the company. I've learned to take anything mgt say's with a huge grain of salt because they are the fox who's watching the hen house. I've seen too many people lose money because they they relied on everything mgt say's as gospel. Sometimes people become too emotionally invested in their investments and it impairs their vision and common sense.

I have been at this for over 37 yrs in the markets. I've learned to question everything and everyone, especially mgt. This has saved me a lot of money over the yrs. I was fortunate enough to get in this one at current levels and will see how things play out over the next 6 months.


"Tough times don't last....tough people do"
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist